Correlation Between Cns Pharmaceuticals and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Cns Pharmaceuticals and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Hepion Pharmaceuticals.
Diversification Opportunities for Cns Pharmaceuticals and Hepion Pharmaceuticals
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cns and Hepion is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cns Pharmaceuticals and Hepion Pharmaceuticals
Given the investment horizon of 90 days Cns Pharmaceuticals is expected to generate 0.72 times more return on investment than Hepion Pharmaceuticals. However, Cns Pharmaceuticals is 1.39 times less risky than Hepion Pharmaceuticals. It trades about -0.13 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.26 per unit of risk. If you would invest 565.00 in Cns Pharmaceuticals on December 27, 2024 and sell it today you would lose (424.00) from holding Cns Pharmaceuticals or give up 75.04% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Cns Pharmaceuticals vs. Hepion Pharmaceuticals
Performance |
Timeline |
Cns Pharmaceuticals |
Hepion Pharmaceuticals |
Cns Pharmaceuticals and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cns Pharmaceuticals and Hepion Pharmaceuticals
The main advantage of trading using opposite Cns Pharmaceuticals and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |